levodopa has been researched along with Diarrhea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, P; Deptula, D; Dorflinger, E; Kurth, M; LeWitt, P; Pedder, S; Shulman, LM; Waters, CH | 1 |
| Baas, H; Beiske, AG; Ghika, J; Jackson, M; Oertel, WH; Poewe, W; Ransmayr, G | 1 |
| Eshel, Y; Korczyn, AD | 1 |
| Boismare, F; Chadelaud, M; Chretien, P; Daoust, M; Moore, N; Saligaut, C | 1 |
3 trial(s) available for levodopa and Diarrhea
| Article | Year |
|---|---|
The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD.
Topics: Aged; Antiparkinson Agents; Area Under Curve; Carbazoles; Diarrhea; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Protein Kinase Inhibitors; Treatment Outcome | 2004 |
Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment. The Tolcapone Stable Study Group.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzophenones; Diarrhea; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Nitrophenols; Parkinson Disease; Placebos; Sickness Impact Profile; Tolcapone; Treatment Outcome | 1997 |
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients.
Topics: Aged; Antiparkinson Agents; Benserazide; Benzophenones; Catechol O-Methyltransferase Inhibitors; Diarrhea; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Europe; Female; Humans; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome | 1998 |
3 other study(ies) available for levodopa and Diarrhea
| Article | Year |
|---|---|
Stalevo for Parkinson's disease.
Topics: Carbidopa; Catechols; Diarrhea; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levodopa; Nausea; Nitriles; Parkinson Disease | 2004 |
Abolition of oxotremorine effects by L-DOPA pretreatment.
Topics: Animals; Catalepsy; Diarrhea; Dose-Response Relationship, Drug; Drug Interactions; Humans; Levodopa; Male; Mice; Oxotremorine; Tears; Tremor | 1979 |
Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
Topics: Administration, Oral; Animals; Choline; Cytidine Diphosphate Choline; Diarrhea; Female; Hypothermia; Levodopa; Mice; Oxotremorine; Salivation; Syndrome; Tremor | 1985 |